SUBSCRIBE
SUBSCRIBE

Australia

Disappearing Device From Abbott Laboratories Keeps Arteries Open Without Metal ‘Spider’
September 9, 2010
 · 
1 min read
Brain Cells Determine Obesity -- Not Lack of Willpower: Monash University Study
September 9, 2010
 · 
1 min read
Sleep Deprivation May Spur Serious Mental Problems, University of Sydney Study Finds
September 1, 2010
 · 
1 min read
Switching Statins Often Leads to Wrong Doses, University of Melbourne Study
August 30, 2010
 · 
1 min read
Forceps Delivery Linked to Later Pelvic Organ Prolapse, University of Sydney Reveals
August 25, 2010
 · 
1 min read
Researchers to Study Men With Pregnancy Symptoms, Wakito University Study
August 24, 2010
 · 
1 min read
Acetaminophen Tied to Asthma in Adolescents, Medical Research Institute of New Zealand Study
August 13, 2010
 · 
1 min read
Asthma Inhaler Link To Prostate Cancer Is Overblown, Cancer Epidemiology Centre Study
August 12, 2010
 · 
1 min read
What Is the NDM-1 Superbug? Drug-Resistant Health Threat Explained, Australian National University Study
August 12, 2010
 · 
1 min read
Drug Development
Snail Venom Inspires Powerful Pain Reliever, University of Queensland Study
August 11, 2010
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging
February 27, 2026
 · 
8 min read
Press Releases
Anteris Reports 2025 Financial Results and Provides Corporate Update
February 27, 2026
 · 
6 min read
Press Releases
Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial
February 26, 2026
 · 
5 min read
Press Releases
Immuron Reports HY26 Results and Strategic Reset
February 25, 2026
 · 
9 min read
Press Releases
AdvanCell Showcases Novel TheraPb Phase 2 Study Design of ADVC001 for the Treatment of Metastatic Prostate Cancer at ASCO GU Symposium 2026
February 24, 2026
 · 
5 min read
Press Releases
Neurala Biosciences Appoints Spyros Papapetropoulos, MD, PhD, as Board Chair
February 24, 2026
 · 
1 min read
Press Releases
Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)
February 24, 2026
 · 
4 min read
Press Releases
Gyder Surgical announces first commercial surgical cases in the United States performed by Dr. Paul M. Lombardi, M.D., at the Tri-County Orthopedics’ Joint Replacement Institute outpatient center
February 22, 2026
 · 
2 min read
Press Releases
Telix to Participate in Oppenheimer and TD Cowen Conferences
February 20, 2026
 · 
5 min read
Press Releases
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
February 19, 2026
 · 
16 min read
Press Releases
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
February 18, 2026
 · 
9 min read
Press Releases
Klotho Neurosciences Receives Patent Claims in Australia for Composition and Use of Human Secreted Klotho Protein (“s-KL”) Isoform of the Human Klotho Gene Sequence
February 18, 2026
 · 
4 min read
Press Releases
Icon Group Deploys ChartCheck Adaptive Across Australia as Radformation Secures USFDA 510(k) Clearance
February 18, 2026
 · 
4 min read
Press Releases
Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging
February 18, 2026
 · 
10 min read
Press Releases
Australian Breast Cancer Innovators Close $27M Private Funding Round
February 12, 2026
 · 
5 min read
Press Releases
ImmuneSensor Therapeutics Doses First Patient with Aicardi Goutières Syndrome (AGS) in Phase 1b Clinical Study of cGAS inhibitor, IMSB301
February 12, 2026
 · 
5 min read
Press Releases
Amplia Therapeutics Announces Opening of US Sites for Amplicity Pancreatic Cancer Trial
February 11, 2026
 · 
4 min read
Press Releases
Genprex Announces IP Australia’s Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
February 10, 2026
 · 
8 min read
Press Releases
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC
February 8, 2026
 · 
4 min read
Press Releases
Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market
February 5, 2026
 · 
5 min read
Load More